Company Moves to Larger Headquarters and Expands Team as it
Prepares for Commercialization of Clarifi^™ Imaging
System

IRVINE, Calif.–(BUSINESS WIRE)–Modulated Imaging, recognized leader in optical imaging solutions for
noninvasive assessment of tissue health, announced today that it has
officially changed its name to Modulim.

With the company entering the next stage of its growth, they are moving
to a larger headquarters (2400 Barranca in Irvine, CA) and are actively
expanding the sales, marketing, engineering, and clinical applications
teams.

In keeping with the new name and headquarters, the company has also
launched an enhanced and updated website, modulim.com.

“While paying homage to the effort we’ve already invested in our
groundbreaking technology, the Modulim name is much more than a simple
contraction of ‘Modulated Imaging,’” said David Cuccia, PhD, Modulim’s
founding CEO and CTO. “It’s also a representation of our newly honed
focus on point-of-care diagnostics. As we evolve and grow, we have
become more than an imaging company. We’re also a software company, a
data/analytics company, and a clinical solutions company, dedicated to
helping clinicians prevent diabetic foot ulcers and other complications
due to compromised circulation.”

“As we enter the next phase of our evolution,” added Richard Oberreiter,
COO, “we are excited and driven by our mission—to deliver transformative
optical imaging solutions that help clinicians diagnose and prevent
vascular dysfunction, empowering people to live healthier, longer, more
fulfilling lives. There is no clearer expression of that ambitious goal
than the masthead of our new website; ‘an ounce of prevention is
priceless.’”

Among the first big moves for Modulim under the new name will be the
national launch of its groundbreaking Clarifi^™ Imaging
system. Powered by Modulim’s proprietary optical imaging technique,
spatial frequency domain imaging (SFDI), Clarifi offers clinicians a
fast, reliable, objective method of assessing tissue oxygen saturation
and hemoglobin concentration and distribution in the tissue. The
technology is able to provide clinicians with an early warning system
for complications due to compromised circulation, including diabetic
foot ulcers.

About Modulim:

Modulim is a pioneer in subsurface optical imaging powered by spatial
frequency domain imaging (SFDI), an advanced imaging technique
co-invented by CEO/CTO David Cuccia, PhD. SFDI deciphers the reflection,
absorbance, and scattering of light in tissue to more accurately measure
key biomarkers for assessing tissue health. The proprietary technology
helps clinicians identify compromised circulation and perfusion by
measuring microvascular tissue oxygenation and hemoglobin concentration
and distribution. As a result, the company’s solution can help
clinicians identify patients with compromised circulation for earlier
intervention. With widespread adoption, this approach could save
thousands of limbs and lives, as well as billions of dollars in
treatment costs. For more information visit modulim.com.

Contacts

Gary Marston
VP Sales and Marketing
(949) 825-5075
[email protected]

Paul Williams
Media Relations
(310) 569-0023
[email protected]